ROBERTO MIGNONE - 21 Feb 2026 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Director
Signature
/s/ John G. Saia, as attorney-in-fact for Roberto A. Mignone
Issuer symbol
GH
Transactions as of
21 Feb 2026
Net transactions value
$0
Form type
4
Filing time
23 Feb 2026, 17:47:02 UTC
Previous filing
22 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
MIGNONE ROBERTO Director 3100 HANOVER STREET, PALO ALTO /s/ John G. Saia, as attorney-in-fact for Roberto A. Mignone 23 Feb 2026 0001258394

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH Common Stock Options Exercise $0 +264 +6.7% $0.000000 4,223 21 Feb 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH Restricted Stock Units Options Exercise $0 -264 -3% $0.000000 8,448 21 Feb 2026 Common Stock 264 $0.000000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock unit award granted on November 8, 2024 vests over a four-year period. 25% of the shares subject to such award vested on the one-year anniversary of October 21, 2024 and the remaining 75% vests monthly for the three-year period thereafter.
F2 Not applicable for Restricted Stock Units.